Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosis

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2024-11-28
DOI
https://doi.org/10.1016/j.jhepr.2024.101287
Citations
3
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
1.11
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosis

Yueping Liu, Jing Hao, Lijuan Niu, Hui Fang et al.
3 citations
JHEP Reports
Hepatocellular Carcinoma Treatment and Prognosis
1.11
article

Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosis

Yueping Liu, Jing Hao, Lijuan Niu, Hui Fang, Huiying Zeng, B. Chen, Ye‐Xiong Li, Jianxiong Wu, Shulian Wang, Liming Wang, Wenwen Zhang, Jingbo Wang, Feng Ye, Hong Zhao, Fan Wu, Yan Song, Yirui Zhai, Wei Sun, Ningning Lu, Shunan Qi, Lingxia Xin, Yong-Wen Song, Yuan Tang
article en
3 citations

Abstract

No abstract available for this paper.
JHEP ReportsVol. 7(3)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Openalex Percentile: Top 21%
Hepatocellular Carcinoma Treatment and Prognosis
1.11
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosis — Yueping Liu, Jing Hao, et al. · JHEP Reports (2024) | TGRS Research Map | TGRS